PMID- 28168795 OWN - NLM STAT- MEDLINE DCOM- 20170828 LR - 20181202 IS - 1522-7278 (Electronic) IS - 1520-4081 (Linking) VI - 32 IP - 6 DP - 2017 Jun TI - Nonylphenol increases tumor formation and growth by suppressing gender-independent lymphocyte proliferation and macrophage activation. PG - 1679-1687 LID - 10.1002/tox.22385 [doi] AB - Nonylphenol (NP) is a well-known endocrine disruptor that influences sexual and reproductive development. Here, we investigated whether NP affects immune responses that are associated with tumor initiation and progression. When spleen cells were incubated with lipopolysaccharide (LPS) and concanavalin A in the presence of 10(-4) M NP, the proliferation of B and T lymphocytes was reduced compared with that in controls, in a gender-independent fashion. While 10(-4) M NP also decreased the production of nitric oxide (NO) in LPS-stimulated bone marrow-derived macrophages (BMDMs), no changes in NO production were detected following treatment with 10(-5) M NP. LPS-stimulated expression of iNOS, COX2, IL-6 and TNF-alpha in BMDMs was reduced after 6 or 18 hours of incubation with 10(-5) M NP. Furthermore, when mice were pre-exposed to NP for 7 days prior to the injection of B16F10 melanoma cells, the rates of tumor nodule formation and relative tumor growth were higher than those in the control group. In vivo immunosuppressive effect was also clarified by the inhibition of proliferation in B/T lymphocyte and cytokine production in peritoneal macrophages from the mice pretreated with NP for 7 days. Taken together, these data demonstrate that NP could affect the immune responses of lymphocytes and macrophages, leading to the suppression of their tumor-preventing ability. This suggests that individuals at high risk for tumor development should avoid frequent exposure to NP and other endocrine disruptors. CI - (c) 2017 Wiley Periodicals, Inc. FAU - Lee, Jae-Wook AU - Lee JW AD - Department of Bioscience and Biotechnology, Sejong University, Seoul, 05006, Republic of Korea. FAU - Han, Hae-Kyoung AU - Han HK AD - Department of Bioscience and Biotechnology, Sejong University, Seoul, 05006, Republic of Korea. FAU - Park, Sojin AU - Park S AD - Department of Bioscience and Biotechnology, Sejong University, Seoul, 05006, Republic of Korea. FAU - Moon, Eun-Yi AU - Moon EY AD - Department of Bioscience and Biotechnology, Sejong University, Seoul, 05006, Republic of Korea. LA - eng PT - Journal Article DEP - 20170207 PL - United States TA - Environ Toxicol JT - Environmental toxicology JID - 100885357 RN - 0 (Endocrine Disruptors) RN - 0 (Interleukin-6) RN - 0 (Lipopolysaccharides) RN - 0 (Phenols) RN - 0 (Tumor Necrosis Factor-alpha) RN - 11028-71-0 (Concanavalin A) RN - 31C4KY9ESH (Nitric Oxide) RN - 79F6A2ILP5 (nonylphenol) RN - EC 1.14.13.39 (NOS2 protein, human) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) SB - IM MH - Animals MH - B-Lymphocytes/drug effects MH - Cell Line, Tumor MH - Cell Proliferation/drug effects MH - Concanavalin A/immunology MH - Endocrine Disruptors/*toxicity MH - Interleukin-6/metabolism MH - Lipopolysaccharides/immunology MH - Lymphocyte Activation/drug effects MH - Lymphocytes/drug effects/*immunology MH - Macrophage Activation/*drug effects MH - Macrophages, Peritoneal/*drug effects/immunology MH - Male MH - Melanoma, Experimental/*chemically induced/immunology MH - Mice MH - Nitric Oxide/metabolism MH - Nitric Oxide Synthase Type II/metabolism MH - Phenols/*toxicity MH - Spleen/cytology/drug effects MH - T-Lymphocytes/drug effects MH - Tumor Necrosis Factor-alpha/metabolism OTO - NOTNLM OT - B/T lymphocytes OT - endocrine disruptor OT - macrophages OT - nonylphenol OT - tumor growth EDAT- 2017/02/09 06:00 MHDA- 2017/08/29 06:00 CRDT- 2017/02/08 06:00 PHST- 2016/08/29 00:00 [received] PHST- 2016/11/20 00:00 [revised] PHST- 2016/11/30 00:00 [accepted] PHST- 2017/02/09 06:00 [pubmed] PHST- 2017/08/29 06:00 [medline] PHST- 2017/02/08 06:00 [entrez] AID - 10.1002/tox.22385 [doi] PST - ppublish SO - Environ Toxicol. 2017 Jun;32(6):1679-1687. doi: 10.1002/tox.22385. Epub 2017 Feb 7.